Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan. (Q44115534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Wei-Lun Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chung-Tai Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ay-Huey Huang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jiunn-Jong Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hsiao-Bai Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hsiu-Chi Cheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Bor-Shyang Sheu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

20 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

210-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori and antibiotic resistance

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

In vitro activity of gemifloxacin against Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Levofloxacin-resistant Helicobacter pylori in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2012.00935.X

10.1111/J.1523-5378.2012.00935.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json

release_rhvafl3oirdpvcv5dx3xig7xem

29 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rhvafl3oirdpvcv5dx3xig7xem

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22515359%20AND%20SRC:MED&resulttype=core&format=json